SODM-OX Serotonergic Oxytocinergic Dopaminergic Modulation Optimized Extract
Indications for anxiolytic, pro-social, antidepressant, and focus/ADHD research
-1 Item Items
This product is no longer in stock
Warning: Last items in stock!
Availability date:
SODM-OX
SODM-OX Serotonergic Oxytocinergic Dopaminergic Modulation Optimized Extract
Indications for anxiolytic, pro-social, antidepressant, and focus/ADHD research
Recipient :
* Required fields
or Cancel
SODM-OX Serotonergic Oxytocinergic Dopaminergic Modulation Optimized Extract
Source: Proprietary
Using guided screening techniques and developed from scientifically engineered cultured strains SODM-OX was developed with the neurotransmitter modulating characteristics aimed to mimic the effects of MDAI/MDMA with a lower efficacy threshold (ceiling of effect), no tolerance or abuse potential, and no toxicity or detrimental residual effects on neurotransmitter pathways.
The predominant goal was for expression of the favorable characteritics with anĀ integral high therapeutic index.
Doses assayed inĀ mice models indicate a range of effect at 10-30mg/kg with a ceiling of effect on locomotor stimulation at 30mg/ml with efficacy at 35% of the maximal effciacy of MDMA.
Future Theorized Human Use Trials
Future trials would be looked to entail dose assays from 40mg to 200mg for goals related to the therapeutic benefits of this class, including anxiety-related conditions, particularly social anxiety disorders.
Solubility:
Mostly soluble within a 1:1 to 1:2 solution of alcohol:water at ~50-150mg/ml
USAGE: For Research Use Only! Not For Use in Humans.